(1)
A Review of the Genetic Variants Affecting Efficacy and Adverse Effects of Standard of Care Treatment in Patients With Chronic Myelogenous Leukemia. Precis. Med. Com. 2022, 2 (1), 43-58. https://doi.org/10.55627/pmc.002.01.0045.